WATSON 425 (Aspirin, Butalbital, Caffeine and Codeine 325 mg / 50 mg / 40 mg / 30 mg)

Pill with imprint WATSON 425 is Blue & Yellow, Capsule-shape and has been identified as Aspirin, butalbital, caffeine and codeine phosphate 325 mg / 50 mg / 40 mg / 30 mg. It is supplied by Watson Pharmaceuticals.

Aspirin/butalbital/caffeine/codeine is used in the treatment of headache and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Aspirin/butalbital/caffeine/codeine 325 mg / 50 mg / 40 mg / 30 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 425

Save up to 80% off prescription medications

Click here for your free Discount Card

Aspirin, butalbital, caffeine and codeine phosphate

Imprint:

WATSON 425

Strength:

325 mg / 50 mg / 40 mg / 30 mg

Color:

Blue & Yellow

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Narcotic analgesic combinations

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

3 - Moderate abuse potential

Labeler / Supplier:

Watson Pharmaceuticals

National Drug Code (NDC):

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.